June 24 (Reuters) - Alumis aims to raise as much as
$317.7 million in its U.S. initial public offering, the therapy
developer said on Monday.
(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by
Sriraj Kalluvila)